About the Center of Excellence

Rx-360’s Center of Excellence is dedicated to enhancing global supply chain security in the pharmaceutical industry

Rx-360 has been accepted as a Pilot Center of Excellence (CoE) for the APEC Regulatory Harmonization Steering Committee. The pilot will be focused on the Global medical Product Supply Chain Integrity Work Area Roadmap.

Our primary purpose is continuing to develop effective education around the APEC Supply Chain Security Toolkit, established in 2017.

Driving Our Purpose

Economic Growth in the APAC Region
In 2023, the Asia-Pacific (APAC) region experienced a strong economic recovery, with growth accelerating to 4.5% year-over-year, up from 3.3% in 2022. This growth signals a robust rebound and positions the region for continued expansion across industries in the coming years. (S&P Global)

Asia-Pacific Pharmaceutical Logistics Market Outlook
The Asia-Pacific pharmaceutical logistics market is on track for significant growth, expected to reach USD 152.79 billion in 2024 and USD 211.16 billion by 2029, growing at a compound annual growth rate (CAGR) of 6.68%. This market expansion reflects increased demand for pharmaceutical products and the logistics solutions needed to support them.
(Mordor Intelligence)

APEC SCS Toolkit: Enhancing Supply Chain Security
This resource is to help stakeholders identify and prevent counterfeit and substandard medical products in the supply chain. By providing critical knowledge and best practices, the Toolkit promotes safer supply chains and enhances global medical product distribution, ensuring greater safety and security in the marketplace.

A Message From Jim Fries, CEO

“This is a tremendous honor for our consortium to be able to serve the APEC mission around medical product safety. We look forward to working with the other Centers of Excellence, US Pharmacopeia, and Taylor’s University in Malaysia, to enhance the already great educational offerings available to the industry”

About APEC Regulatory Harmonization Steering Committee

The Regulatory Harmonization Steering Committee (RHSC) was formed in June 2009 under the auspices of APEC to promote a strategic approach to regulatory harmonization by undertaking activities of greatest value to regulatory authorities and regulated industries. It is a network of regulatory experts from regulatory agencies in APEC Economies, industry and academia with the vision of achieving greater regulatory convergence within the APEC economies by 2020. The RHSC does not seek to develop new guidances but is designed to play a complementary role to other regional international regulatory initiatives.

About Rx-360

Rx-360 is dedicated to fostering strong partnerships between pharmaceutical manufacturers and suppliers to uphold the integrity of supply chains, guided by member-led working groups and an audit program.

We are a community of thought leaders in the life sciences and medical device sectors, united in our commitment to driving meaningful change within the industry.

Our Mission

Our mission is to protect patient safety by sharing information and developing processes related to the integrity of the healthcare supply chain and the quality of its materials.

Contact a Dedicated Rx-360 CoE Representative

Jim Fries

Rx-360 CEO

215.317.4476

Ryan Kelly

Sr. Director Supply Chain Security & Brand Protection